2160 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. It offers research, development and commercialization of medical devices for valvular heart diseases. The firm provides services through its subsidiaries. The company was founded on January 10, 2019 and is headquartered in Shanghai, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
2160 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company